120 related articles for article (PubMed ID: 8939386)
1. Usefulness of flow cytometric detection of cell surface interleukin-6 receptors in human myeloma cell lines.
Chen YH; Feng XX; Hagen K
Clin Lab Haematol; 1996 Sep; 18(3):161-9. PubMed ID: 8939386
[TBL] [Abstract][Full Text] [Related]
2. Differential interleukin-6 (IL-6) responses of three established myeloma cell lines in the presence of soluble human IL-6 receptors.
Diamant M; Hansen MB; Rieneck K; Svenson M; Yasukawa K; Bendtzen K
Leuk Res; 1996 Apr; 20(4):291-301. PubMed ID: 8642840
[TBL] [Abstract][Full Text] [Related]
3. A monoclonal anti-human IL-6 receptor antibody inhibits the proliferation of human myeloma cells.
Huang YW; Vitetta ES
Hybridoma; 1993 Oct; 12(5):621-30. PubMed ID: 8300137
[TBL] [Abstract][Full Text] [Related]
4. Constituents of autocrine IL-6 loops in myeloma cell lines and their targeting for suppression of neoplastic growth by antibody strategies.
Villunger A; Egle A; Kos M; Hittmair A; Maly K; Greil R
Int J Cancer; 1996 Feb; 65(4):498-505. PubMed ID: 8621234
[TBL] [Abstract][Full Text] [Related]
5. Mouse anti-human interleukin-6 receptor monoclonal antibody inhibits proliferation of fresh human myeloma cells in vitro.
Goto H; Shimazaki C; Tatsumi T; Yamagata N; Hirata T; Ashihara E; Oku N; Inaba T; Fujita N; Koishihara Y
Jpn J Cancer Res; 1994 Sep; 85(9):958-65. PubMed ID: 7961126
[TBL] [Abstract][Full Text] [Related]
6. Differential regulation of interleukin-6 receptors by interleukin-6 and interferons in multiple myeloma cell lines.
Lasfar A; Wietzerbin J; Billard C
Eur J Immunol; 1994 Jan; 24(1):124-30. PubMed ID: 8020547
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of inhibition of IL-6-mediated immunoglobulin secretion by dexamethasone and suramin in human lymphoid and myeloma cell lines.
Shiao RT; McLeskey SB; Khera SY; Wolfson A; Freter CE
Leuk Lymphoma; 1996 Apr; 21(3-4):293-303. PubMed ID: 8726410
[TBL] [Abstract][Full Text] [Related]
8. Resistance to interleukin 6 in human non-small cell lung carcinoma cell lines: role of receptor components.
Ganapathi MK; Weizer AK; Borsellino S; Bukowski RM; Ganapathi R; Rice T; Casey G; Kawamura K
Cell Growth Differ; 1996 Jul; 7(7):923-9. PubMed ID: 8809410
[TBL] [Abstract][Full Text] [Related]
9. Major role of the soluble interleukin-6/interleukin-6 receptor complex for the proliferation of interleukin-6-dependent human myeloma cell lines.
Gaillard JP; Liautard J; Klein B; Brochier J
Eur J Immunol; 1997 Dec; 27(12):3332-40. PubMed ID: 9464821
[TBL] [Abstract][Full Text] [Related]
10. Sequence, expression and function of an mRNA encoding a soluble form of the human interleukin-6 receptor (sIL-6R).
Lust JA; Jelinek DF; Donovan KA; Frederick LA; Huntley BK; Braaten JK; Maihle NJ
Curr Top Microbiol Immunol; 1995; 194():199-206. PubMed ID: 7895493
[TBL] [Abstract][Full Text] [Related]
11. Interleukin 6 receptor superantagonists are potent inducers of human multiple myeloma cell death.
Demartis A; Bernassola F; Savino R; Melino G; Ciliberto G
Cancer Res; 1996 Sep; 56(18):4213-8. PubMed ID: 8797594
[TBL] [Abstract][Full Text] [Related]
12. Retinoic acid modulates the in vivo and in vitro growth of IL-6 autocrine human myeloma cell lines via induction of apoptosis.
Levy Y; Labaume S; Colombel M; Brouet JC
Clin Exp Immunol; 1996 Apr; 104(1):167-72. PubMed ID: 8603522
[TBL] [Abstract][Full Text] [Related]
13. Soluble interleukin-6 receptor (sIL-6R), a new prognostic factor in multiple myeloma.
Kyrtsonis MC; Dedoussis G; Zervas C; Perifanis V; Baxevanis C; Stamatelou M; Maniatis A
Br J Haematol; 1996 May; 93(2):398-400. PubMed ID: 8639436
[TBL] [Abstract][Full Text] [Related]
14. Soluble interleukin-6 receptor is released from receptor-bearing cell lines in vitro.
Nakajima T; Yamamoto S; Cheng M; Yasukawa K; Hirano T; Kishimoto T; Tokunaga T; Honda M
Jpn J Cancer Res; 1992 Apr; 83(4):373-8. PubMed ID: 1506271
[TBL] [Abstract][Full Text] [Related]
15. Absence of IL-6 receptor expression in fresh childhood Burkitt's lymphoma cells and induction of IL-6 receptors by Epstein-Barr virus in vitro.
Tomeczkowski J; zur Stadt U; Reiter A; Welte K; Sykora KW
Br J Haematol; 1997 May; 97(2):400-8. PubMed ID: 9163607
[TBL] [Abstract][Full Text] [Related]
16. Differential expression and ligand-induced modulation of the human interleukin-6 receptor on interleukin-6-responsive cells.
Schwabe M; Zhao J; Kung HF
J Biol Chem; 1994 Mar; 269(10):7201-9. PubMed ID: 8125932
[TBL] [Abstract][Full Text] [Related]
17. Differential sensitivity of human myeloma cell lines and normal bone marrow colony forming cells to a recombinant diphtheria toxin-interleukin 6 fusion protein.
Chadwick DE; Jean LF; Jamal N; Messner HA; Murphy JR; Minden MD
Br J Haematol; 1993 Sep; 85(1):25-36. PubMed ID: 8251407
[TBL] [Abstract][Full Text] [Related]
18. Effect of IL-6 receptor antisense oligodeoxynucleotide on in vitro proliferation of myeloma cells.
Keller ET; Ershler WB
J Immunol; 1995 Apr; 154(8):4091-8. PubMed ID: 7706747
[TBL] [Abstract][Full Text] [Related]
19. Establishment of a novel myeloma cell line KPMM2 carrying t(3;14)(q21;q32), which proliferates specifically in response to interleukin-6 through an autocrine mechanism.
Goto H; Shimazaki C; Tatsumi T; Yamagata N; Fujita N; Tsuchiya M; Koishihara Y; Ohsugi Y; Nakagawa M
Leukemia; 1995 Apr; 9(4):711-8. PubMed ID: 7723407
[TBL] [Abstract][Full Text] [Related]
20. Soluble interleukin-6 (IL-6) receptor in the sera of pregnant women forms a complex with IL-6 and augments human chorionic gonadotropin production by normal human trophoblasts through binding to the IL-6 signal transducer.
Matsuzaki N; Neki R; Sawai K; Shimoya K; Okada T; Sakata M; Saji F; Koishihara Y; Ida N
J Clin Endocrinol Metab; 1995 Oct; 80(10):2912-7. PubMed ID: 7559874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]